To Install, click here.
- Levulan® Kerastick®
Levulan® Kerastick®Levulan® Kerastick® plus blue light illumination using the BLU-U® blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses (Grade 1 or 2) of the face or scalp.
Learn More >> - BLU-U®
BLU-U®The BLU-U is a unique blue light that can kill the P. acnes bacteria in your skin.
Learn More >> - ClindaReachTM
ClindaReachTMClindaReach is indicated for the topical treatment of acne vulgaris and is only available by prescription.
Learn More >>
News
November 3, 2008
DUSA Pharmaceuticals Reports Third Quarter 2008 Corporate Highlights and Financial Results
November 4, 2008
DUSA Pharmaceuticals to present at the Rodman & Renshaw 10th Annual Healthcare Conference
November 3, 2008
Third Quarter 2008 Corporate Highlights and Financial Results Conference Call
Welcome
DUSA Pharmaceuticals, Inc.® is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan Photodynamic Therapy (PDT) technology platform, and complementary dermatology products.
DUSA's other dermatology product includes ClindaReach which was acquired from Sirius Laboratories, Inc. ClindaReach targets patients with acne. DUSA is also developing certain internal indications of Levulan PDT. DUSA is based in Wilmington, MA.
